A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License ...

CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP ...

The Food and Drug Administration (FDA) on Wednesday approved the updated version of Pfizer’s and Moderna’s COVID-19 vaccines for this upcoming respiratory viral season, but limited the approval to ...

As a group of advisers to the US Centers for Disease Control and Prevention met this week to discuss recommendations on who should get the updated Covid-19 shot this season, a newly published analysis ...

The US Food and Drug Administration (FDA) has green-lit updated COVID-19 vaccines for the 2025–26 season for select groups, but confusion is already mounting over how physicians and insurers will ...

In an observational study of United States veterans, the 2024 to 2025 COVID-19 vaccine lowered the risk for severe COVID-19 outcomes, providing strong evidence to guide public health discussions ...